Vlahov D - Search Results

1

Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.

Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. Farzadegan H, et al. Among authors: vlahov d. J Infect Dis. 1993 Aug;168(2):327-31. doi: 10.1093/infdis/168.2.327. J Infect Dis. 1993. PMID: 8335969

2

Prospective study of infective endocarditis among injection drug users.

Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. Wilson LE, et al. Among authors: vlahov d. J Infect Dis. 2002 Jun 15;185(12):1761-6. doi: 10.1086/340827. Epub 2002 May 31. J Infect Dis. 2002. PMID: 12085322

3

Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.

Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. Sterling TR, et al. Among authors: vlahov d. J Infect Dis. 2002 Oct 15;186(8):1181-5. doi: 10.1086/343807. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355373 Free article.

4

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.

Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Wang C, et al. Among authors: vlahov d. J Infect Dis. 2004 Sep 15;190(6):1046-54. doi: 10.1086/422848. Epub 2004 Aug 17. J Infect Dis. 2004. PMID: 15319852

5

Changes in blood-borne infection risk among injection drug users.

Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Mehta SH, et al. Among authors: vlahov d. J Infect Dis. 2011 Mar 1;203(5):587-94. doi: 10.1093/infdis/jiq112. Epub 2011 Jan 31. J Infect Dis. 2011. PMID: 21282191 Free PMC article.

6

Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.

Margolick JB, Muñoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson KE. Margolick JB, et al. Among authors: vlahov d. JAMA. 1992 Mar 25;267(12):1631-6. JAMA. 1992. PMID: 1347321

7

Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.

Chaisson RE, Taylor E, Margolick JB, Muñoz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Chaisson RE, et al. Among authors: vlahov d. J Acquir Immune Defic Syndr (1988). 1992;5(5):456-60. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1348535

8

Bacterial infections and skin cleaning prior to injection among intravenous drug users.

Vlahov D, Sullivan M, Astemborski J, Nelson KE. Vlahov D, et al. Public Health Rep. 1992 Sep-Oct;107(5):595-8. Public Health Rep. 1992. PMID: 1410243 Free PMC article.

9

Knowledge of therapeutics for human immunodeficiency virus infection among intravenous drug users.

Smith MD, Celentano DD, Solomon L, Astemborski J, Vlahov D. Smith MD, et al. Among authors: vlahov d. J Infect Dis. 1992 Sep;166(3):685-6. doi: 10.1093/infdis/166.3.685. J Infect Dis. 1992. PMID: 1500759 No abstract available.

10

Prognostic indicators for development of AIDS among intravenous drug users.

Muñoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE. Muñoz A, et al. Among authors: vlahov d. J Acquir Immune Defic Syndr (1988). 1992;5(7):694-700. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1613668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

699 results

Search Page

Filters